Summerset Group Holdings Ltd (ASX:SNZ) profit up 26%

Summerset Group Holdings Ltd (ASX: SNZ) has advised its underlying profit for the six months to June 30 2018 will rise

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

New Zealand retirement home and hospital group Summerset Group Holdings Ltd (ASX: SNZ) has advised its underlying profit for the six months to June 30, 2018, will be up between 21% and 26% on the previous corresponding period.

According to an earnings guidance announcement today, Summerset will report underlying profit of between NZ$43 million and NZ$45 million for the period off the back of "strong development margins" on settled homes over the first half.

Sales and resales volumes are also on track with full financial results to be handed down on August 14.

On home soil companies intending to cash in on the ageing population include Ramsay Health Care Limited Fully Paid Ord. Shrs (ASX: RHC) which has been having a tough time of late as its share price tumbled to multi-year lows off the back of challenging industry dynamics and private health insurance declines.

Goldman Sachs placed a sell rating on Ramsay earlier this month, but many investors keen on its growth prospects in the private hospital sector might see it as hovering in buy territory.

Healthscope Ltd (ASX: HSO) shares have also tumbled into the red of late, down 0.2% to $2.24 at the time of writing.

Motley Fool contributor Carin Pickworth has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Three health professionals at a hospital smile for the camera.
Healthcare Shares

Orthocell caps 26% surge this week with first US Military Surgery

The company's commercial rollout is off to a good start.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

This ASX health tech stock just hit a new record high. Could it go even higher?

Morgans believes there's still upside to be had.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Down almost 20% this year, how high could Mesoblast shares go?

The forward pipeline is looking promising.

Read more »

Three health professionals at a hospital smile for the camera.
Healthcare Shares

Down 38% this year, is it finally time to buy low on CSL, ResMed and Pro Medicus shares?

These three stocks might be too cheap to ignore.

Read more »

Modern accountant woman in a light business suit in modern green office with documents and laptop.
Healthcare Shares

How much would $10,000 become if CSL shares returned to their record high?

After a sharp decline, CSL is in a new phase. The question is what happens next.

Read more »

A man clenches his fists with glee having seen the share price go up on the computer screen in front of him.
Healthcare Shares

Why this ASX biotech stock just rocketed 89% today

Immutep shares rocket after a fresh FDA win

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Orthocell shares soar 22% on landmark US breakthrough

The company has been given approval to sell Remplir in more than 220 hospitals in the US.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

This ASX biotech stock just jumped again as its lead drug trial moves ahead

The latest trial milestone sends this ASX biotech stock higher today.

Read more »